CHA AI Healthkare
Korea ExchangeTotal Valuation
CHA AI Healthkare carries a market capitalization of 56.62B, placing it among publicly traded companies globally. Its enterprise value stands at 88.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 56.62B |
| Enterprise Value | 88.14B |
Valuation Ratios
CHA AI Healthkare trades at a trailing price-to-earnings ratio of 34.94. The price-to-sales ratio is 12.68, and the price-to-book ratio stands at -0.69.
| PE Ratio | 34.94 |
| PS Ratio | 12.68 |
| PB Ratio | -0.69 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | -16.44 |
| P/OCF Ratio | -16.01 |
Enterprise Valuation
| EV / Sales | 11.77 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
CHA AI Healthkare maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.53, indicating elevated leverage, while an interest coverage ratio of -3.52 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.21 |
| Quick Ratio | 0.96 |
| Debt / Equity | 40.53 |
| Debt / EBITDA | -3.92 |
| Interest Coverage | -3.52 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.24 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 3.91 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | -2.02M |
| Effective Tax Rate | N/A |
Stock Price Statistics
CHA AI Healthkare's stock has declined approximately -5.10753% over the past 52 weeks. The 50-day moving average sits at 7,199.60, while the 200-day moving average is 10,295.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.10753% |
| 50-Day Moving Average | 7,199.60 |
| 200-Day Moving Average | 10,295.85 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, CHA AI Healthkare generated 7.49B in revenue and converted that into -912.26M in net income, yielding earnings per share of -83.90. EBITDA reached -7.31B, while operating income came in at -7.31B.
| Revenue | 7.49B |
| Gross Profit | 2.03B |
| Operating Income | -7.31B |
| Pretax Income | -898.02M |
| Net Income | -912.26M |
| EBITDA | -7.31B |
| EBIT | -7.31B |
| Earnings Per Share (EPS) | -83.90 |
Balance Sheet
CHA AI Healthkare holds 35.50B in cash and equivalents against 28.66B in total debt, resulting in a net debt position of -5.73B. Total book value stands at -138.47B, with working capital of 7.84B providing operational flexibility.
| Cash & Cash Equivalents | 35.50B |
| Total Debt | 28.66B |
| Net Debt | -5.73B |
| Equity (Book Value) | -138.47B |
| Book Value Per Share | -13,120.75 |
| Working Capital | 7.84B |
Cash Flow
CHA AI Healthkare produced -5.93B in operating cash flow over the past twelve months. After subtracting -74.71M in capital expenditures, free cash flow totaled -6.01B - equivalent to -569.36 per share.
| Operating Cash Flow | -5.93B |
| Capital Expenditures | -74.71M |
| Free Cash Flow | -6.01B |
| FCF Per Share | -569.36 |
Margins
CHA AI Healthkare operates with a gross margin of 27.03, reflecting its pricing power and cost economics. The operating margin of -97.51 and net profit margin of -12.18 provide insight into operational efficiency.
| Gross Margin | 27.03 |
| Operating Margin | -97.51 |
| Pretax Margin | -11.99 |
| Profit Margin | -12.18 |
| EBITDA Margin | -97.51 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -83.41 |
| FCF Yield | -6.08 |
Stock Splits
CHA AI Healthkare's most recent stock split took place on December 19, 2022 with a 20:1 split ratio.
| Last Split Date | 12/19/2022 |
| Split Ratio | 20:1 |
Scores
CHA AI Healthkare posts an Altman Z-Score of -0.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.47 |